RIGL CIK: 1034842

Rigel Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.15
FY22:
0.12
FY23:
0.10
FY24:
0.14
FY25:
0.24
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.01
FY22:
0.02
FY23:
0.02
FY24:
0.03
FY25:
0.27
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.13
FY23:
0.12
FY24:
0.16
FY25:
0.51

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.06
FY22:
0.07
FY23:
0.05
FY24:
0.06
FY25:
0.10
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.07
FY22:
0.08
FY23:
0.09
FY24:
0.10
FY25:
0.02
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
−0.01
FY23:
−0.03
FY24:
0.00
FY25:
0.39
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
0.17
FY22:
0.13
FY23:
0.12
FY24:
0.16
FY25:
0.51

All amounts in billions USD Data sources:SEC EDGARTwelve Data